2010 Speakers/ Chairs
- Dr Matti Aapro, Dean, Multidisciplinary Oncology Institute, Clinique de Genolier, SWITZERLAND
- Prof Janet L. Abrahm, MD, FACP, FAAHPM/Division Chief, Adult Palliative Care, Dana Farber Cancer Institute, Associate Professor of Medicine, Harvard Medical School, USA
- Prof René Adam, Department of Surgery, Paul - Brousse Hospital, FRANCE
- Dr Costas G Alexopoulos, MD(Ath), MRCP(UK), FRCP(Lon), Consultant Medical Oncologist, Iatriko Medical Centre, GREECE
- Dr Fabrice André, MD, PhD, Institut Gustave Roussy, FRANCE
- Prof Mickael Aoun, Institute Jules Bordet, BELGIUM
- Prof Deborah Armstrong, Associate Professor of Oncology, Gynecology & Obstetrics, Johns Hopkins Kimmel Cancer Center, USA
- Prof Dirk Arnold, MD, Associate Professor, Department of Medical Oncology and Haematology, Martin Luther University, University Hospital, GERMANY
- Dr Athanasios Athanasiou, MD, PhD, Director, Metaxa Cancer Hospital, GREECE
- Prof Aristotle Bamias, Assistant Professor, Department of Clinical Therapeutics, Medical School, National & Kapodistrian University of Athens, GREECE
- Dr Vassilis Barbounis, Director of Oncology Unit “Ippokratio” Athens General Hospital, GREECE
- Dr Ion Belenis, Consultant Thoracic Surgeon, Evangelismos Hospital, GREECE
- Dr Francesco Bertoni, Head of The Functional Genomics & Lymphoma Unit, Oncology Institute of Southern Switzerland (IOSI), Editor-In-Chief, Hematological Oncology Journal, Wiley Blackwell, SWITZERLAND
- Dr Axel Bex, Department of Urology Division of Surgical Oncology, The Netherlands Cancer Institute, THE NETHERLANDS
- Dr James Brennan, Consultant Clinical Psychologist/ Honorary Senior Lecturer in Palliative Medicine, Bristol Haematology & Oncology Centre / University of Bristol, UK
- Silvia Camporesi, Associate Editor, Ecancer Medical Science, ITALY
- Dr Andrés Cervantes, Head of Section, Hematology and Medical Oncology Department, Hospital Clinico Universitario De Valencia, SPAIN
- Prof Wendy Chen, MD MPH, Assistant Professor of Medicine, Dana Farber Cancer Institute, Harvard Medical School, USA
- Prof Finbarr E. Cotter, Head of Experimental Haematology, Department of Medical Oncology, Barts and London School of Medicine, Editor-in-Chief, British Journal of Haematology, UK
- Prof Michael Cullen, Medical Oncologist, University Hospital Birmingham, UK
- Dr Giuseppe Curigliano, Senior Deputy Director, Division of Medical Oncology, European Institute of Oncology, ITALY
- Dr John Davis, MD, Assistant Professor, The University of Texas, MD Anderson Cancer Center, USA
- Dr Thierry de Baére, MD, Head of Interventional Radiology Department, Institute Gustave Roussy, FRANCE
- Prof Aimery De Gramont, Head of Oncology Department, Hospital St Antoine, FRANCE
- Dr Madhav V. Dhodapkar, Bunker Professor of Medicine and Immunobiology, Chief, Section of Hematology, Yale University, USA
- Prof Volker Diehl, Professor of Medicine, University of Cologne, GERMANY
- Prof Anna Efremidis, Assistant Professor - Director Medical Oncology, "Agios Savvas" Anticancer Hospital Of Athens, GREECE
- Prof Alexander Eggermont, General Director, Cancer Institute Gustave Roussy, FRANCE
- Prof Tim Eisen, Department of Oncology University of Cambridge, Addenbrooke’s Hospital, UK
- Prof Ian Fentiman, Professor of Surgical Oncology, GKT School of Medicine, Guy’s Hospital, UK
- Dr Keith Flaherty, Director of Developmental Therapeutics, Massachusetts General Hospital Cancer Center, Editorial Board, Pigment Cell & Melanoma Research, USA
- Dr Sara Gandini, Staff Scientist, European Institute of Oncology, ITALY
- Prof Christos Georgiades, MD PhD, Associate Professor of Radiology & Surgery, Clinical Director, Department of Vascular & Interventional Radiology, Johns Hopkins Hospital, USA
- Prof Jean-Francois Geschwind, MD, Professor of Radiology, Surgery & Oncology, Chief, Department of Vascular & Interventional Radiology, Johns Hopkins Hospital, USA
- Prof Dr Lutz Gissmann, Head of Division, DKFZ, GERMANY
- Prof Helen Gogas, Ass. Professor of Medical Oncology, 1st Department of Medicine, Medical School, University of Athens, GREECE
- Prof Peter Goldstraw, Professor οf Thoracic Surgery, Imperial College London, Consultant Thoracic Surgeon, Royal Brompton Hospital, UK
- Prof Mary Gospodarowicz, Medical Director, PMH Cancer Program, Princess Margaret Hospital, Professor and Chair, Faculty of Medicine, University of Toronto, CANADA
- Dr Frank Greco, MD, Director, Sarah Cannon Cancer Center, Tennessee Oncology, USA
- Prof Thomas Gruenberger, Head, HB-Service, Department of General Surgery, Medical University Vienna, AUSTRIA
- Prof Valentina Guarneri, Assistant Professor, Modena University Hospital, ITALY
- Dr John D. Hainsworth, Chief Scientific Officer, Sarah Cannon Research Institute, USA
- Dr Kevin Joseph Harrington, Senior Lecturer and Honorary Consultant in Clinical Oncology, Head and Neck Unit, Gynaecological Oncology Unit and Melanoma Unit, Royal Marsden Hospital, UK
- Prof Alan Horwich, Professor of Radiotherapy, Institute of Cancer Research, UK
- Prof Stephen Johnston, Consultant Medical Oncologist, Royal Marsden Hospital, UK
- Prof John A. Karagiannis, Professor/ Consultant Gastroenterologist, Constantopoulio Athens General Hospital "Agia Olga", GREECE
- Prof Thomas Kieber-Emmons, Professor of Pathology, University of Arkansas for Medical Sciences, Deputy Director, Winthrop P. Rockefeller Cancer Institute, USA
- Prof Jean Klastersky, Professor of Medicine, Université Libre de Bruxelles, BELGIUM
- Dr Katerina Kotsori, Clinical Fellow in Medical Oncology, Royal Marsden Hospital, UK
- Prof Deborah Kuban, MD, Professor, The University of Texas, M. D. Anderson Cancer Center, USA
- Prof Roberto La Bianca, Divisione Di Oncologia Medicale, Hospedali Riuniti, ITALY
- Prof Thierry Le Chevalier, Department of Medicine, Institute Gustave Roussy, FRANCE
- Prof Jonathan Ledermann, Director & Professor of Medical Oncology, UCL Cancer Research UK Centre, UK
- Prof Riccardo Lencioni, Director, Division of Diagnostic Imaging and Intervention, University of Pisa, ITALY
- Dr. Len Lichtenfeld, MD, MACP, Deputy Chief Medical Officer, American Cancer Society, USA
- Prof Dr Peter Lichter, Head of Division, Chief Editor, German Cancer Research Center, Division of Molecular Genetics, International Journal of Cancer, GERMANY
- Dr Eric Lim, Consultant Thoracic Surgeon, Royal Brompton Hospital, Senior Lecturer, National Heart and Lung Institute, Imperial College, UK
- Dr Sonja Loges, Group Leader, Physician, University Hospital Hamburg-Eppendorf, University Comprehensive Cancer Center, II. Medical Clinic and Institute for Tumor Biology, GERMANY
- Prof Christopher J. Logothetis, Chairman / Professor, Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, USA
- Dr Paul Lorigan, Senior Lecturer in Medical Oncology, School of Cancer and Imaging Sciences, Faculty of Medical & Human Sciences, University of Manchester, Christie Hospital NHS Trust, UK
- Dr Fergus Macbeth, Director of the Centre for Clinical Practice, National Institute for Health and Clinical Excellence (NICE), UK
- Dr Iain Macdougall, Consultant Nephrologist, King’s College Hospital, London, UK
- Prof Patrick W. Mantyh, PhD, JD, Professor of Pharmacology, Department Of Pharmacology, University Of Arizona, USA
- Prof John L Marshall, MD, Chief, Hematology and Oncology , Professor of Medicine and Oncology, Associate Director of Clinical Research, Director, Developmental Therapeutics and GI Oncology Lombardi Comprehensive Cancer Center, USA
- Prof Shahla Masood, Professor and Chair, Department of Pathology, University of Florida College of Medicine, Jacksonville, USA
- Dr Athena Matakidou, CRUK Clinician Scientist Fellow Tumour Modelling and Cancer Medicine Laboratory, CRUK Cambridge Research Institute, UK
- Prof J. Gordon Mcvie, MD, FRCP, FRCS Ed, FMedSci, DSc(Hon), Senior Consultant, Scientific Directorate, European Institute of Oncology, ITALY
- Dr Aisha Miah, Clinical Research Fellow, The Royal Marsden NHS Foundation Trust, UK
- Dr Gary Middleton, Consultant Medical Oncologist, Royal Surrey County Hospital, UK
- Dr David Miles, Miles Mount Vernon Hospital, UK
- Prof Dr Kurt Miller, Director, Charité, Campus Benjamin Franklin, GERMANY
- Prof Dr Jan Mollenhauer, Director, Head Molecular Oncology Lundbeckfonden Center of Excellence NanoCAN, Institute of Molecular Medicine, University of Southern Denmark, DENMARK
- Clare Moynihan, Senior Research Fellow, Medical Sociologist, The Institute of Cancer Research and The Royal Marsden Hospital Foundation Trust (honorary position), UK
- Prof Dr Carsten Müller-Tidow, MD, Professor of Medicine, University Hospital of Munster, GERMANY
- Raj Naik, Consultant and Clinical Director, Northern Gynaecological Oncology Centre, Gateshead, UK
- Prof Dr Carsten Nieder, Professor, Head of the Radiation Oncology Programme, Department of Oncology, Nordland Hospital, NORWAY
- Prof Hans W Nijman, MD, PhD, Professor of Gynaecologic Oncology & Immunotherapy, Department Of Gynaecologic Oncology, University Medical Center Groningen, University of Groningen, THE NETHERLANDS
- Prof Marianna Nuti, University Full Professor, Department of Experimental Medicine, University of Rome Sapienza, ITALY
- Dr Jens Overgaard, Department of Experimental Clinical Oncology, Aarhus University Hospital, DENMARK
- Prof Lars Påhlman, Uppsala University, SWEDEN
- Dr Panagiotis Pantelakos, Head of Radiation Oncology Department, "Attikon" General University Hospital, GREECE
- Dr Demetris Papamichael, Consultant Medical Oncologist, B.O. Cyprus Oncology Centre, CYPRUS
- Prof Christophe Penna, Professor of Surgery, MD, PhD, Ambroise-Paré Hospital, Department of digestive and oncologic surgery, FRANCE
- Prof George Pentheroudakis, Assistant Professor in Oncology, Medical School, University of Ioannina, GREECE
- Dr Christophe Pomel, Oncologic surgeon, Centre Jean Perrin Cancer Center, FRANCE
- Dr Sanjay Popat, Clinical Senior Lecturer and Consultant Medical Oncologist, Imperial College and The Royal Marsden Hospital, UK
- Prof Eric Pujade – Lauraine, Head of Medical Oncology, Department Hôpital Hotel-Dieu, FRANCE
- Prof Kenneth V. Rolston, The University of Texas, MD Anderson Cancer Center, USA
- Prof Philippe Rougier, MD, PHD, Head of the department of Digestive Oncology, Hôpital Europeen Georges Pompidou (HEGP), FRANCE
- Prof George Samonis, Professor Of Medicine, Medical Oncologist - Infectious Diseases Specialist, Medical School, The University Of Crete, GREECE
- Prof Marc Sanson, P&M Curie University, Pitié-Salpêtrière Hospital, FRANCE
- Prof Fritz H. Schröder, Professor of Urology, Erasmus Medical Center, THE NETHERLANDS
- Prof Dr Ben Slotman, Department of Radiation Oncology, VU University Medical Center, THE NETHERLANDS
- Prof Kjetil Søreide, Associate Professor of Surgery, Surgeon, Stavanger University Hospital, Editor, British Journal of Surgery, NORWAY
- Prof Nick Spirtos, Professor, The University Of Nevada School Of Medicine, Director Of The Division Of Gynecologic Oncology, Women's Cancer Center Of Nevada, USA
- Prof Nicholas Stathakis, University of Thessaly, GREECE
- Dr George Stathopoulos, Oncologist, Medical Oncology Department, Henry Dunant Hospital, GREECE
- Dr Astrid T. Stormorken, Locum Consultant, The Royal Marsden Hospital, London, UK
- Prof Jeffrey Tobias, Professor of Cancer Medicine and Consultant in Clinical Oncology, University College London, UK
- Dr William D. Travis, Attending Thoracic Pathologist, Department Of Pathology, Memorial Sloan Kettering Cancer Center, USA
- Dr Nicholas Turner, Senior Lecturer and Honorary Consultant In Medical Oncology, Royal Marsden Hospital and Institute of Cancer Research, UK
- Prof Cornelia Ulrich, NCT Director/Head of DKFZ Division of Preventive Oncology, German Cancer Research Center / National Center of Tumor Diseases (NCT) Heidelberg, GERMANY
- Prof Dr Jan Van Meerbeek, Professor in Thoracic Oncology, Ghent University Hospital, BELGIUM
- Dr Gauri Varadhachary, MD, University of Texas, M.D. Anderson Cancer Center, USA
- Dr Charles J. Vecht, Neuro-Oncologist, Medical Centre The Hague, THE NETHERLANDS
- Prof Dr Magnus von Knebel – Doeberitz, Medical Director, Department of Applied Tumor Biology, Institute of Pathology, University of Heidelberg and Clinical Cooperation Unit “Applied Tumor Biology”,German Cancer Research Center,GERMANY
- Prof Jamie H. Von Roenn, MD, Professor of Medicine, Department of Medicine, Division of Hematology/Oncology, Northwestern University, Feinberg School of Medicine, Medical Director, Home Hospice Program, Northwestern Memorial Hospital, USA
- Prof Heather Wakelee, Assistant Professor Of Medicine, Oncology, Stanford University School of Medicine, Cancer Center, USA
- Prof Maggie Watson, Head Of Service, Royal Marsden Hospital, UK
- Prof Dr Michael Weller, Department of Neurology, University Hospital Zurich, SWITZERLAND
- Prof Bertram Wiedenmann, Head of Department, Charite - Universitatsmedizin Berlin, Campus Kirchow Klinikum, Medizinische Klinik M. S. Hepatologie Und Gastroenterologie, GERMANY
- Dr Peer Wille-Jørgensen, Consultant Surgeon, Department of Surgery K, Bisperbjerg Hospital, DENMARK
- Dr Norman Wolmark, Chairman, NSABP (National Surgical Adjuvant Breast and Bowel Project), USA
- Prof Dr Nikos Zamboglou, Professor of Oncology, Director Haematology Oncology, Albert Ludwigs University of Freiburg, Adult Oncologist, Klinikum Offenbach GmbH, GERMANY



